What is the current Fagron market capitalization?
The current market capitalization of Fagron is 1.31 B EUR.
Fagron Market capitalization 2024
Fagron Market capitalization
1.31 B EUR
Ticker
FAGR.BR
ISIN
BE0003874915
WKN
A0M103
In 2024, Fagron's market cap stood at 1.31 B EUR, a 10.08% increase from the 1.19 B EUR market cap in the previous year.
The Fagron Market capitalization history
| YEAR | Market Capitalization (undefined EUR) |
|---|---|
| 2023 | 1.17 |
| 2022 | 1.07 |
| 2021 | 1.3 |
| 2020 | 1.42 |
| 2019 | 1.22 |
| 2018 | 1.04 |
| 2017 | 0.82 |
| 2016 | 0.39 |
| 2015 | 0.92 |
| 2014 | 1.13 |
| 2013 | 0.64 |
| 2012 | 0.41 |
| 2011 | 0.34 |
| 2010 | 0.28 |
| 2009 | 0.21 |
| 2008 | 0.25 |
| 2007 | 0.25 |
| 2006 | - |
| 2005 | - |
| 2004 | - |
Fagron Aktienanalyse
What does Fagron do?
Fagron NV is an internationally operating company that focuses on the development and production of customized medications for pharmacies and hospitals. The company was founded in 1990 in Rotterdam, Netherlands. The beginnings of Fagron NV were in the Netherlands, where the company was established as Roterodamum Chemie BV. In the late 1990s, the company was converted into a holding company called Arseus NV, which later received the name Fagron. In 2012, Fagron was listed on the Euronext stock exchange in Brussels. Fagron operates globally and has locations in Europe, North America, Latin America, the United Arab Emirates, Asia, and Australia. Fagron's business model is based on the production of specialized medications for individual patient needs. The company offers a wide range of pharmaceutical active ingredients, raw materials, and processing services. There is also the possibility to develop and manufacture customized formulations tailored to the needs of patients. Fagron not only manufactures customized medications but also provides training and support for pharmacies and hospitals. Fagron operates in three main divisions: Specialty Pharma (hospital care), Community Pharma (prescription and non-prescription medications), and Compounding Services (custom formulations). The Specialty Pharma division specializes in medications for use in hospitals. It offers a wide range of products that can be used in the treatment of conditions such as cancer, HIV, and tuberculosis. These medications are manufactured in various dosage forms, such as injections, infusions, and tablets. The Community Pharma division focuses on prescription and non-prescription medications. Both branded and generic medications are offered. These are delivered directly to pharmacies, hospitals, and clinics. The Compounding Services division specializes in the production of customized medications. Fagron works closely with pharmacies and hospitals to meet individual needs. This includes, for example, the manufacture of medications in specific dosages or the combination of several active ingredients in a custom formulation. Fagron offers a wide range of products, including hormones, pain medications, cancer drugs, medications for the treatment of skin diseases, ophthalmic products, and anti-infectives. Pharmaceutical active ingredients and raw materials are also offered. Overall, Fagron is a global leader in the production of customized medications. It has extensive experience and expertise in the manufacturing of pharmaceutical formulations and offers a wide range of products and services. The various divisions of Fagron allow the company to meet the diverse needs of its customers and maintain its position as a leading company in the pharmaceutical industry. Fagron ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Fagron's Market Capitalization
Fagron's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Fagron's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Fagron's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Fagron’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Fagron stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Fagron.
How has the market capitalization of Fagron developed in recent years?
The market capitalization of Fagron has increased/decreased by 10.08% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Fagron?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Fagron?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Fagron have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Fagron pay?
Over the past 12 months, Fagron paid a dividend of 0.25 EUR . This corresponds to a dividend yield of about 1.39 %. For the coming 12 months, Fagron is expected to pay a dividend of 0.28 EUR.
What is the dividend yield of Fagron?
The current dividend yield of Fagron is 1.39 %.
When does Fagron pay dividends?
Fagron pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Fagron?
Fagron paid dividends every year for the past 0 years.
What is the dividend of Fagron?
For the upcoming 12 months, dividends amounting to 0.28 EUR are expected. This corresponds to a dividend yield of 1.58 %.
In which sector is Fagron located?
Fagron is assigned to the 'Health' sector.
Wann musste ich die Aktien von Fagron kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Fagron from 5/23/2024 amounting to 0.3 EUR, you needed to have the stock in your portfolio before the ex-date on 5/21/2024.
When did Fagron pay the last dividend?
The last dividend was paid out on 5/23/2024.
What was the dividend of Fagron in the year 2023?
In the year 2023, Fagron distributed 0.2 EUR as dividends.
In which currency does Fagron pay out the dividend?
The dividends of Fagron are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Fagron
Our stock analysis for Fagron Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fagron Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.